Welcome to LookChem.com Sign In|Join Free
  • or
methyl 2-ethyl-5-nitrobenzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

103205-48-7

Post Buying Request

103205-48-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

103205-48-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 103205-48-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,2,0 and 5 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 103205-48:
(8*1)+(7*0)+(6*3)+(5*2)+(4*0)+(3*5)+(2*4)+(1*8)=67
67 % 10 = 7
So 103205-48-7 is a valid CAS Registry Number.

103205-48-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-ethyl-5-nitrobenzoate

1.2 Other means of identification

Product number -
Other names 2-ethyl-5-nitro-benzoic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103205-48-7 SDS

103205-48-7Relevant academic research and scientific papers

Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists

-

Page/Page column 23, (2010/02/05)

The present invention provides phenyl urea and phenyl thiourea derivatives which are non-peptide antagonists of human orexin receptors, in particular orexin-1 receptors, of formula (I) in which: Z represents oxygen or sulfur; and R1to R7represent various substituent groups; and pharmaceutically acceptable salts thereof. In particular, these compounds are of potential use in the treatment of obesity including obesity observed in Type 2(non-insulin-dependent) diabetes patients and/or sleep disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 103205-48-7